Stevanato to expedite delivery of visual inspection systems to Catalent sites
The high-speed machines will support biologic and vaccine programs at locations in US and Italy
Stevanato Group has expanded its collaboration with Catalent to include delivery of advanced visual inspection systems to help with potential Covid-19 pandemic programs, biologics and sterile injectable products.
Under the expanded arrangement, Catalent has ordered Plus 400 LKD automatic and PWL semi-automatic visual inspection machines from Stevanato and will install the equipment at its sites in Bloomington, IN and Anagni, Italy.
"
(Images courtesy of Stevanato Group)" alignment="right"/>
The move is intended to support various customer and quality assurance programs through the use of advanced technologies to inspect biologics and sterile injectables, maximizing the detection rate while keeping false rejections low.
Privately held Stevanato Group said it plans to speed delivery of the high precision and high throughput equipment to the Catalent manufacturing operations.
Strategic Trends in Pharmaceutical Manufacturing for Industry Leaders
March 10th 2025This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.
